Global Artificial Heart Lung Machines Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

Global Artificial Heart Lung Machines Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030


Summary

Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.

According to APO Research, The global Artificial Heart Lung Machines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North American market for Artificial Heart Lung Machines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Artificial Heart Lung Machines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Artificial Heart Lung Machines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Artificial Heart Lung Machines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Artificial Heart Lung Machines include LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica and Tianjin Medical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Artificial Heart Lung Machines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Artificial Heart Lung Machines, also provides the sales of main regions and countries. Of the upcoming market potential for Artificial Heart Lung Machines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Artificial Heart Lung Machines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Artificial Heart Lung Machines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Artificial Heart Lung Machines sales, projected growth trends, production technology, application and end-user industry.

Artificial Heart Lung Machines segment by Company

LivaNova (Sorin)
Getinge (Maquet)
Medtronic
Terumo CV Group
Braile Biomedica
Tianjin Medical
Artificial Heart Lung Machines segment by Type

Single Roller Pump HLM
Double Roller Pump HLM
Artificial Heart Lung Machines segment by Application

Cardiac Surgery
Lung Transplant Operation
Acute Respiratory Failure Treatment
Others
Artificial Heart Lung Machines segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Artificial Heart Lung Machines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Artificial Heart Lung Machines market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Artificial Heart Lung Machines significant trends, drivers, influence factors in global and regions.
6. To analyze Artificial Heart Lung Machines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Heart Lung Machines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Heart Lung Machines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Heart Lung Machines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Artificial Heart Lung Machines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artificial Heart Lung Machines industry.
Chapter 3: Detailed analysis of Artificial Heart Lung Machines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Artificial Heart Lung Machines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Artificial Heart Lung Machines in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Artificial Heart Lung Machines Sales Value (2019-2030)
1.2.2 Global Artificial Heart Lung Machines Sales Volume (2019-2030)
1.2.3 Global Artificial Heart Lung Machines Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Artificial Heart Lung Machines Market Dynamics
2.1 Artificial Heart Lung Machines Industry Trends
2.2 Artificial Heart Lung Machines Industry Drivers
2.3 Artificial Heart Lung Machines Industry Opportunities and Challenges
2.4 Artificial Heart Lung Machines Industry Restraints
3 Artificial Heart Lung Machines Market by Company
3.1 Global Artificial Heart Lung Machines Company Revenue Ranking in 2023
3.2 Global Artificial Heart Lung Machines Revenue by Company (2019-2024)
3.3 Global Artificial Heart Lung Machines Sales Volume by Company (2019-2024)
3.4 Global Artificial Heart Lung Machines Average Price by Company (2019-2024)
3.5 Global Artificial Heart Lung Machines Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Artificial Heart Lung Machines Company Manufacturing Base & Headquarters
3.7 Global Artificial Heart Lung Machines Company, Product Type & Application
3.8 Global Artificial Heart Lung Machines Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Artificial Heart Lung Machines Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Artificial Heart Lung Machines Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 Artificial Heart Lung Machines Market by Type
4.1 Artificial Heart Lung Machines Type Introduction
4.1.1 Single Roller Pump HLM
4.1.2 Double Roller Pump HLM
4.2 Global Artificial Heart Lung Machines Sales Volume by Type
4.2.1 Global Artificial Heart Lung Machines Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Artificial Heart Lung Machines Sales Volume by Type (2019-2030)
4.2.3 Global Artificial Heart Lung Machines Sales Volume Share by Type (2019-2030)
4.3 Global Artificial Heart Lung Machines Sales Value by Type
4.3.1 Global Artificial Heart Lung Machines Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Artificial Heart Lung Machines Sales Value by Type (2019-2030)
4.3.3 Global Artificial Heart Lung Machines Sales Value Share by Type (2019-2030)
5 Artificial Heart Lung Machines Market by Application
5.1 Artificial Heart Lung Machines Application Introduction
5.1.1 Cardiac Surgery
5.1.2 Lung Transplant Operation
5.1.3 Acute Respiratory Failure Treatment
5.1.4 Others
5.2 Global Artificial Heart Lung Machines Sales Volume by Application
5.2.1 Global Artificial Heart Lung Machines Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Artificial Heart Lung Machines Sales Volume by Application (2019-2030)
5.2.3 Global Artificial Heart Lung Machines Sales Volume Share by Application (2019-2030)
5.3 Global Artificial Heart Lung Machines Sales Value by Application
5.3.1 Global Artificial Heart Lung Machines Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Artificial Heart Lung Machines Sales Value by Application (2019-2030)
5.3.3 Global Artificial Heart Lung Machines Sales Value Share by Application (2019-2030)
6 Artificial Heart Lung Machines Market by Region
6.1 Global Artificial Heart Lung Machines Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Artificial Heart Lung Machines Sales by Region (2019-2030)
6.2.1 Global Artificial Heart Lung Machines Sales by Region: 2019-2024
6.2.2 Global Artificial Heart Lung Machines Sales by Region (2025-2030)
6.3 Global Artificial Heart Lung Machines Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Artificial Heart Lung Machines Sales Value by Region (2019-2030)
6.4.1 Global Artificial Heart Lung Machines Sales Value by Region: 2019-2024
6.4.2 Global Artificial Heart Lung Machines Sales Value by Region (2025-2030)
6.5 Global Artificial Heart Lung Machines Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Artificial Heart Lung Machines Sales Value (2019-2030)
6.6.2 North America Artificial Heart Lung Machines Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Artificial Heart Lung Machines Sales Value (2019-2030)
6.7.2 Europe Artificial Heart Lung Machines Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Artificial Heart Lung Machines Sales Value (2019-2030)
6.8.2 Asia-Pacific Artificial Heart Lung Machines Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Artificial Heart Lung Machines Sales Value (2019-2030)
6.9.2 Latin America Artificial Heart Lung Machines Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Artificial Heart Lung Machines Sales Value (2019-2030)
6.10.2 Middle East & Africa Artificial Heart Lung Machines Sales Value Share by Country, 2023 VS 2030
7 Artificial Heart Lung Machines Market by Country
7.1 Global Artificial Heart Lung Machines Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Artificial Heart Lung Machines Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Artificial Heart Lung Machines Sales by Country (2019-2030)
7.3.1 Global Artificial Heart Lung Machines Sales by Country (2019-2024)
7.3.2 Global Artificial Heart Lung Machines Sales by Country (2025-2030)
7.4 Global Artificial Heart Lung Machines Sales Value by Country (2019-2030)
7.4.1 Global Artificial Heart Lung Machines Sales Value by Country (2019-2024)
7.4.2 Global Artificial Heart Lung Machines Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Artificial Heart Lung Machines Sales Value Growth Rate (2019-2030)
7.5.2 Global Artificial Heart Lung Machines Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Artificial Heart Lung Machines Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Artificial Heart Lung Machines Sales Value Growth Rate (2019-2030)
7.6.2 Global Artificial Heart Lung Machines Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Artificial Heart Lung Machines Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Artificial Heart Lung Machines Sales Value Growth Rate (2019-2030)
7.7.2 Global Artificial Heart Lung Machines Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Artificial Heart Lung Machines Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Artificial Heart Lung Machines Sales Value Growth Rate (2019-2030)
7.8.2 Global Artificial Heart Lung Machines Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Artificial Heart Lung Machines Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Artificial Heart Lung Machines Sales Value Growth Rate (2019-2030)
7.9.2 Global Artificial Heart Lung Machines Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Artificial Heart Lung Machines Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Artificial Heart Lung Machines Sales Value Growth Rate (2019-2030)
7.10.2 Global Artificial Heart Lung Machines Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Artificial Heart Lung Machines Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Artificial Heart Lung Machines Sales Value Growth Rate (2019-2030)
7.11.2 Global Artificial Heart Lung Machines Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Artificial Heart Lung Machines Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Artificial Heart Lung Machines Sales Value Growth Rate (2019-2030)
7.12.2 Global Artificial Heart Lung Machines Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Artificial Heart Lung Machines Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Artificial Heart Lung Machines Sales Value Growth Rate (2019-2030)
7.13.2 Global Artificial Heart Lung Machines Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Artificial Heart Lung Machines Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Artificial Heart Lung Machines Sales Value Growth Rate (2019-2030)
7.14.2 Global Artificial Heart Lung Machines Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Artificial Heart Lung Machines Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Artificial Heart Lung Machines Sales Value Growth Rate (2019-2030)
7.15.2 Global Artificial Heart Lung Machines Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Artificial Heart Lung Machines Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Artificial Heart Lung Machines Sales Value Growth Rate (2019-2030)
7.16.2 Global Artificial Heart Lung Machines Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Artificial Heart Lung Machines Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Artificial Heart Lung Machines Sales Value Growth Rate (2019-2030)
7.17.2 Global Artificial Heart Lung Machines Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Artificial Heart Lung Machines Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Artificial Heart Lung Machines Sales Value Growth Rate (2019-2030)
7.18.2 Global Artificial Heart Lung Machines Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Artificial Heart Lung Machines Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Artificial Heart Lung Machines Sales Value Growth Rate (2019-2030)
7.19.2 Global Artificial Heart Lung Machines Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Artificial Heart Lung Machines Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Artificial Heart Lung Machines Sales Value Growth Rate (2019-2030)
7.20.2 Global Artificial Heart Lung Machines Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Artificial Heart Lung Machines Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Artificial Heart Lung Machines Sales Value Growth Rate (2019-2030)
7.21.2 Global Artificial Heart Lung Machines Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Artificial Heart Lung Machines Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Artificial Heart Lung Machines Sales Value Growth Rate (2019-2030)
7.22.2 Global Artificial Heart Lung Machines Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Artificial Heart Lung Machines Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Artificial Heart Lung Machines Sales Value Growth Rate (2019-2030)
7.23.2 Global Artificial Heart Lung Machines Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Artificial Heart Lung Machines Sales Value Share by Application, 2023 VS 2030
8 Company Profiles
8.1 LivaNova (Sorin)
8.1.1 LivaNova (Sorin) Comapny Information
8.1.2 LivaNova (Sorin) Business Overview
8.1.3 LivaNova (Sorin) Artificial Heart Lung Machines Sales, Value and Gross Margin (2019-2024)
8.1.4 LivaNova (Sorin) Artificial Heart Lung Machines Product Portfolio
8.1.5 LivaNova (Sorin) Recent Developments
8.2 Getinge (Maquet)
8.2.1 Getinge (Maquet) Comapny Information
8.2.2 Getinge (Maquet) Business Overview
8.2.3 Getinge (Maquet) Artificial Heart Lung Machines Sales, Value and Gross Margin (2019-2024)
8.2.4 Getinge (Maquet) Artificial Heart Lung Machines Product Portfolio
8.2.5 Getinge (Maquet) Recent Developments
8.3 Medtronic
8.3.1 Medtronic Comapny Information
8.3.2 Medtronic Business Overview
8.3.3 Medtronic Artificial Heart Lung Machines Sales, Value and Gross Margin (2019-2024)
8.3.4 Medtronic Artificial Heart Lung Machines Product Portfolio
8.3.5 Medtronic Recent Developments
8.4 Terumo CV Group
8.4.1 Terumo CV Group Comapny Information
8.4.2 Terumo CV Group Business Overview
8.4.3 Terumo CV Group Artificial Heart Lung Machines Sales, Value and Gross Margin (2019-2024)
8.4.4 Terumo CV Group Artificial Heart Lung Machines Product Portfolio
8.4.5 Terumo CV Group Recent Developments
8.5 Braile Biomedica
8.5.1 Braile Biomedica Comapny Information
8.5.2 Braile Biomedica Business Overview
8.5.3 Braile Biomedica Artificial Heart Lung Machines Sales, Value and Gross Margin (2019-2024)
8.5.4 Braile Biomedica Artificial Heart Lung Machines Product Portfolio
8.5.5 Braile Biomedica Recent Developments
8.6 Tianjin Medical
8.6.1 Tianjin Medical Comapny Information
8.6.2 Tianjin Medical Business Overview
8.6.3 Tianjin Medical Artificial Heart Lung Machines Sales, Value and Gross Margin (2019-2024)
8.6.4 Tianjin Medical Artificial Heart Lung Machines Product Portfolio
8.6.5 Tianjin Medical Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Artificial Heart Lung Machines Value Chain Analysis
9.1.1 Artificial Heart Lung Machines Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Artificial Heart Lung Machines Sales Mode & Process
9.2 Artificial Heart Lung Machines Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Artificial Heart Lung Machines Distributors
9.2.3 Artificial Heart Lung Machines Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings